vs

Side-by-side financial comparison of Cryoport, Inc. (CYRX) and NETSTREIT Corp. (NTST). Click either name above to swap in a different company.

NETSTREIT Corp. is the larger business by last-quarter revenue ($57.1M vs $45.5M, roughly 1.3× Cryoport, Inc.). NETSTREIT Corp. runs the higher net margin — 10.0% vs -17.5%, a 27.5% gap on every dollar of revenue. On growth, NETSTREIT Corp. posted the faster year-over-year revenue change (24.3% vs 9.6%). Over the past eight quarters, NETSTREIT Corp.'s revenue compounded faster (20.1% CAGR vs 10.4%).

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

NETSTREIT Corp. is a US-headquartered real estate investment trust (REIT) that specializes in acquiring and operating a diversified portfolio of single-tenant net lease commercial properties. Its asset portfolio covers retail, industrial and office categories, primarily catering to investment-grade corporate tenants across the United States market.

CYRX vs NTST — Head-to-Head

Bigger by revenue
NTST
NTST
1.3× larger
NTST
$57.1M
$45.5M
CYRX
Growing faster (revenue YoY)
NTST
NTST
+14.6% gap
NTST
24.3%
9.6%
CYRX
Higher net margin
NTST
NTST
27.5% more per $
NTST
10.0%
-17.5%
CYRX
Faster 2-yr revenue CAGR
NTST
NTST
Annualised
NTST
20.1%
10.4%
CYRX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CYRX
CYRX
NTST
NTST
Revenue
$45.5M
$57.1M
Net Profit
$-8.0M
$5.7M
Gross Margin
47.8%
Operating Margin
-17.0%
34.1%
Net Margin
-17.5%
10.0%
Revenue YoY
9.6%
24.3%
Net Profit YoY
57.4%
235.9%
EPS (diluted)
$-0.19
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYRX
CYRX
NTST
NTST
Q1 26
$57.1M
Q4 25
$45.5M
$52.5M
Q3 25
$44.2M
$48.3M
Q2 25
$45.5M
$48.3M
Q1 25
$41.0M
$45.9M
Q4 24
$41.5M
$44.1M
Q3 24
$38.3M
$41.4M
Q2 24
$39.7M
$39.6M
Net Profit
CYRX
CYRX
NTST
NTST
Q1 26
$5.7M
Q4 25
$-8.0M
$1.3M
Q3 25
$-6.9M
$618.0K
Q2 25
$105.2M
$3.3M
Q1 25
$-12.0M
$1.7M
Q4 24
$-18.7M
$-5.4M
Q3 24
$805.0K
$-5.3M
Q2 24
$-78.0M
$-2.3M
Gross Margin
CYRX
CYRX
NTST
NTST
Q1 26
Q4 25
47.8%
Q3 25
48.2%
Q2 25
47.0%
Q1 25
45.4%
Q4 24
47.0%
Q3 24
45.5%
Q2 24
44.5%
Operating Margin
CYRX
CYRX
NTST
NTST
Q1 26
34.1%
Q4 25
-17.0%
2.6%
Q3 25
-22.5%
1.3%
Q2 25
-21.2%
6.8%
Q1 25
-23.1%
3.7%
Q4 24
-30.7%
-12.3%
Q3 24
-34.9%
-12.8%
Q2 24
-196.5%
-5.8%
Net Margin
CYRX
CYRX
NTST
NTST
Q1 26
10.0%
Q4 25
-17.5%
2.5%
Q3 25
-15.7%
1.3%
Q2 25
231.4%
6.8%
Q1 25
-29.2%
3.7%
Q4 24
-45.1%
-12.3%
Q3 24
2.1%
-12.8%
Q2 24
-196.4%
-5.8%
EPS (diluted)
CYRX
CYRX
NTST
NTST
Q1 26
$0.32
Q4 25
$-0.19
$0.01
Q3 25
$-0.18
$0.01
Q2 25
$2.05
$0.04
Q1 25
$-0.28
$0.02
Q4 24
$-0.42
$-0.07
Q3 24
$-0.02
$-0.07
Q2 24
$-1.62
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYRX
CYRX
NTST
NTST
Cash + ST InvestmentsLiquidity on hand
$411.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$502.6M
$1.5B
Total Assets
$765.0M
$2.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYRX
CYRX
NTST
NTST
Q1 26
Q4 25
$411.2M
Q3 25
$421.3M
Q2 25
$426.0M
Q1 25
$244.0M
Q4 24
$250.6M
Q3 24
$259.4M
Q2 24
$414.9M
Total Debt
CYRX
CYRX
NTST
NTST
Q1 26
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$926.6M
Q1 25
$913.3M
Q4 24
$868.3M
Q3 24
$778.7M
Q2 24
$726.2M
Stockholders' Equity
CYRX
CYRX
NTST
NTST
Q1 26
$1.5B
Q4 25
$502.6M
$1.4B
Q3 25
$513.3M
$1.3B
Q2 25
$519.1M
$1.3B
Q1 25
$398.8M
$1.3B
Q4 24
$401.9M
$1.3B
Q3 24
$418.6M
$1.3B
Q2 24
$400.1M
$1.3B
Total Assets
CYRX
CYRX
NTST
NTST
Q1 26
$2.8B
Q4 25
$765.0M
$2.6B
Q3 25
$774.3M
$2.5B
Q2 25
$773.9M
$2.3B
Q1 25
$699.8M
$2.3B
Q4 24
$703.5M
$2.3B
Q3 24
$701.8M
$2.2B
Q2 24
$852.3M
$2.1B
Debt / Equity
CYRX
CYRX
NTST
NTST
Q1 26
Q4 25
0.76×
Q3 25
0.84×
Q2 25
0.70×
Q1 25
0.70×
Q4 24
0.65×
Q3 24
0.58×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYRX
CYRX
NTST
NTST
Operating Cash FlowLast quarter
$919.0K
Free Cash FlowOCF − Capex
$-4.5M
FCF MarginFCF / Revenue
-10.0%
Capex IntensityCapex / Revenue
12.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYRX
CYRX
NTST
NTST
Q1 26
Q4 25
$919.0K
$109.5M
Q3 25
$2.2M
$28.0M
Q2 25
$-7.3M
$30.6M
Q1 25
$-4.3M
$22.1M
Q4 24
$-5.5M
$90.2M
Q3 24
$447.0K
$25.1M
Q2 24
$-8.0M
$25.4M
Free Cash Flow
CYRX
CYRX
NTST
NTST
Q1 26
Q4 25
$-4.5M
Q3 25
$-1.3M
Q2 25
$-11.7M
Q1 25
$-7.5M
Q4 24
$-10.7M
Q3 24
$-3.8M
Q2 24
$-11.8M
FCF Margin
CYRX
CYRX
NTST
NTST
Q1 26
Q4 25
-10.0%
Q3 25
-2.9%
Q2 25
-25.7%
Q1 25
-18.3%
Q4 24
-25.8%
Q3 24
-9.9%
Q2 24
-29.8%
Capex Intensity
CYRX
CYRX
NTST
NTST
Q1 26
Q4 25
12.0%
Q3 25
7.8%
Q2 25
9.6%
Q1 25
7.7%
Q4 24
12.6%
Q3 24
11.1%
Q2 24
9.5%
Cash Conversion
CYRX
CYRX
NTST
NTST
Q1 26
Q4 25
82.46×
Q3 25
45.27×
Q2 25
-0.07×
9.36×
Q1 25
13.06×
Q4 24
Q3 24
0.56×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CYRX
CYRX

Segment breakdown not available.

NTST
NTST

Rental revenue (including reimbursable)$54.0M95%
Other$3.0M5%

Related Comparisons